Success Story
OrganOx is at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation.
| Region/Nation | South East |
|---|---|
| Sector | Technology |
| Programme | Enterprise Capital Funds |
| Partner |
Its leading product, the metra®, harnesses patented medical technology to preserve donor livers for up to 24 hours prior to transplant. This product has been used in around 4,000 liver transplants.
OrganOx accessed venture capital via the Enterprise Capital Funds (ECF) programme, which it used to fund the clinical studies to secure market approval for its product, a complex class III medical device.
Tags related to this content:
More success stories
Read a success story about Magnitude Biosciences
North East based contract research organisation (CRO) Magnitude Biosciences helps its clients in the health & nutrition, biotech and pharmaceutical industries progress their research projects.
Read a success story about Tribe Tech
Tribe Tech is a disruptive developer and manufacturer of autonomous mining equipment. The Group was founded in late 2019 in Western Australia and has since established a headquarters and manufacturing facility in Northern Ireland.
Read a success story about Barclay & Daughters
Barclay & Daughters is a family-run nationally competitive haulier with over 25 years of industry experience.